Skip to content
healthcare.dev

ANDEXXA

NDC 0310-3200, andexanet alfa, injection, powder, lyophilized, for solution, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-3200
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125586
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-3200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANDEXANET ALFA200 mg/20mL
Package NDCNDC-11Package
0310-3200-04003103200044 VIAL, SINGLE-USE in 1 CARTON (0310-3200-04) / 20 mL in 1 VIAL, SINGLE-USE (0310-3200-01)
0310-3200-05003103200055 VIAL, SINGLE-USE in 1 CARTON (0310-3200-05) / 20 mL in 1 VIAL, SINGLE-USE (0310-3200-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2d9d90a6-63e6-46ef-96ff-dd6519ae7b6c

Use it

Look up 0310-3200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-3200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-3200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.